Outpatient, no comorbidities

Patient Population: Adult
Diagnosis Common Pathogens Drug(s) of First Choice Alternative Drug(s) Comments Expected Duration

Respiratory viruses

S.  pneumoniae

Mycoplasma pneumoniae

Chlamydia pneumoniae

H. influenza



Amoxicillin 1 g PO TID

Consider influenza testing and treatment with oseltamivir

Consider coverage for MRSA and/or Pseudomonas aeruginosa in patients with respiratory isolation of these organisms or receipt of parenteral
5 days

American Journal of Respiratory and Critical Care Medicine, Volume 200, Issue 7, 1 October 2019, Pages e45-e67, https://www.atsjournals.org/doi/full/10.1164/rccm.201908-1581ST